Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Antibiotic assay discs, paper, dispensers, and susceptibility testing products for microbial differentiation and determining antibiotic sensitivity of fastidious and non-fastidious, Gram-negative bacteria including extensively drug-resistant (XDR), multidrug-resistant, and carbapenem-resistant microorganisms. Used in clinical microbiology laboratories worldwide. Constructed of paper, plastic, or metal.
GSA/VA Contract Available on GSA/VA contract for Federal Government customers. Learn More
Determine the susceptibility of microorganisms using manual AST methods and a full range of high quality, easy-to-use antimicrobial susceptibility testing discs.
GSA/VA Contract Available on GSA/VA contract for Federal Government customers. Learn More
Determine the susceptibility of microorganisms using manual AST methods and a full range of high-quality, easy-to-use antimicrobial susceptibility testing discs.
Determine the susceptibility of microorganisms using manual AST methods and a full range of high quality, easy-to-use antimicrobial susceptibility testing discs.
Determine the susceptibility of microorganisms using manual AST methods and a full range of high-quality, easy-to-use antimicrobial susceptibility testing discs.
Determine the susceptibility of microorganisms using manual AST methods and a full range of high-quality, easy-to-use antimicrobial susceptibility testing discs.
Determine the susceptibility of microorganisms using manual AST methods and a full range of high-quality, easy-to-use antimicrobial susceptibility testing discs.
For determining the type of causal agent of infectious diseases and for checking their sensitivity to antibiotics and chemotherapeutic agents in vitro by means of the inhibition zone determination method.
The disc is intended to determine susceptibility of Enterobacterales and Staphylococcus aureus to ceftobiprole, as recognized by the FDA Susceptibility Test Interpretive Criteria (STIC). Ceftobiprole at concentrations of 5 μg should be interpreted at 16 to 18 hours of incubation.